182500-28-3 Usage
General Description
4-bromo-5-methyl-2-nitrophenol is a chemical compound with the molecular formula C7H6BrNO3. It is a derivative of phenol, with a bromine atom attached to the 4th carbon and a methyl group attached to the 5th carbon. Additionally, it has a nitro group attached to the 2nd carbon, giving it unique properties and reactivity. 4-bromo-5-methyl-2-nitrophenol is often used in organic synthesis and as a building block for other chemicals. It is also studied for its potential applications in pharmaceuticals and materials science. However, it is important to handle this compound with care, as it is considered hazardous and toxic if ingested or inhaled. Proper safety measures and handling procedures should be followed when working with 4-bromo-5-methyl-2-nitrophenol.
Check Digit Verification of cas no
The CAS Registry Mumber 182500-28-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,2,5,0 and 0 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 182500-28:
(8*1)+(7*8)+(6*2)+(5*5)+(4*0)+(3*0)+(2*2)+(1*8)=113
113 % 10 = 3
So 182500-28-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H6BrNO3/c1-4-2-7(10)6(9(11)12)3-5(4)8/h2-3,10H,1H3
182500-28-3Relevant articles and documents
cGAS ANTAGONIST COMPOUNDS
-
Paragraph 0434, (2017/11/06)
Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
-
Page/Page column 41-42, (2008/12/06)
The invention provides novel pyrimidine and pyridine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine and pyridine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kinase (ALK) activity, focal adhesion kinase (FAK), zeta-chain-associated protein kinase 70 (ZAP-70), insulin-like growth factor (IGF-1R), or a combination thereof.
